cas：86541-74-4 Benazepril (hydrochloride);CGS14824A 工艺放大

产品名称：cas：86541-74-4 Benazepril (hydrochloride);CGS14824A 工艺放大

产品描述：

Product Name：Benazepril (hydrochloride)

Synonyms：CGS14824A

CAS Number：86541-74-4

M. Wt：460.95

Target：Angiotensin-converting Enzyme (ACE)

Pathway：Metabolic Enzyme/Protease
Approved Type:FDA; NMPA

Biological Activity：Benazepril hydrochloride, an angiotensin converting enzyme inhibitor, which is a medication used to treat high blood pressure.

Target: angiotensin converting enzyme (ACE)
Benazepril hydrochloride is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril hydrochloride is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor [1].
Animals were randomly divided into 4 groups: sham STNx group (control), STNx group, morning benazepril hydrochloride group (MB) and evening benazepril hydrochloride group (EB).Benazepril hydrochloride was intragastrically administered at a dose of 10 mg/kg/day at 07:00 and 19:00 in the MB group and EB group respectively for 12 weeks. All the animals were synchronized to the light:dark cycle of 12:12 for 12 weeks. Systolic blood pressure (SBP), 24-h urinary protein excretion and renal function were measured at 11 weeks. Blood samples and kidneys were collected every 4 h throughout a day to detect the expression pattern of renin activity (RA), angiotensin II (AngII) and aldosterone (Ald) by radioimmunoassay (RIA) and the mRNA expression profile of clock genes (bmal1, dbp and per2) by real-time PCR at 12 weeks. Our results showed that no significant differences were noted in the SBP, 24-h urine protein excretion and renal function between the MB and EB groups. There were no significant differences in average Ald and RA content of a day between the MB group and EB group. The expression peak of bmal1 mRNA was phase-delayed by 4 to 8 h, and the diurnal variation of per2 and dbp mRNA diminished in the MB and EB groups compared with the control and STNx groups. It was concluded when the similar SBP reduction, RAAS inhibition and clock gene profile were achieved with optimal dose of benazepril hydrochloride, morning versus evening dosing of benazepril hydrochloride has the same renoprotection effects [2].
Clinical indications: Congestive heart failure; End stage renal disease; Hypertension
FDA Approved Date:
Toxicity: headaches; cough; Anaphylaxis; angioedema; hyperkalemia

规格：50mg，100mg，500mg，1g，10g，100g以及kg级别等公斤级大包装

配送：惯例下常温包邮

包装：袋装

厂家：西安齐岳生物科技有限公司

关于我们：
西安齐岳生物科技有限公司具备批量生产能力和强大的研发能力，这样的双重优势可以确保企业不仅在满足市场需求上保持高效，同时也在产品创新和技术升级。能够提供100mg，500mg，1g，10g，100g以及kg级别等公斤级大包装。

运输说明:
极低温产品:极低温产品运输过程中加装干冰运输。

低温产品:低温产品运输过程中加装冰袋运输。

常温产品:常温产品运输过程中无需加冰或者特殊包装

温馨提示：西安齐岳生物提供的产品仅用于科研！

随货带检测图谱，提供各种规格包装的价格以及技术资料

温馨提示：仅用于科研

联系我们：

邮箱：2519696869@qq.com

QQ: 2519696869

电话：18066853083

微信：18066853083

公司介绍：

西安齐岳生物科技有限公司是集化学科研和定制与一体的高科技化学公司。业务范围包括化学试剂和产品的研发、生产、销售等。涉及产品为通用试剂的分销、非通用试剂的定制与研发，涵盖生物科技、化学品、中间体和化工材料等领域。
主营产品：COF、MOF单体系列：三蝶烯衍生物、金刚烷衍生物、四苯甲烷衍生物、peg、上转换、石墨烯、光电材料、点击化学、凝集素、载玻片、蛋白质交联剂、脂质体、蛋白、多肽、氨基酸、糖化学等。